180 related articles for article (PubMed ID: 19256504)
1. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.
Birch AM; Birtles S; Buckett LK; Kemmitt PD; Smith GJ; Smith TJ; Turnbull AV; Wang SJ
J Med Chem; 2009 Mar; 52(6):1558-68. PubMed ID: 19256504
[TBL] [Abstract][Full Text] [Related]
2. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
[TBL] [Abstract][Full Text] [Related]
3. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
[TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
[TBL] [Abstract][Full Text] [Related]
7. Novel acyl coenzyme A (CoA): diacylglycerol acyltransferase-1 inhibitors: synthesis and biological activities of diacylethylenediamine derivatives.
Nakada Y; Aicher TD; Le Huerou Y; Turner T; Pratt SA; Gonzales SS; Boyd SA; Miki H; Yamamoto T; Yamaguchi H; Kato K; Kitamura S
Bioorg Med Chem; 2010 Apr; 18(7):2785-95. PubMed ID: 20207151
[TBL] [Abstract][Full Text] [Related]
8. JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.
Tomimoto D; Okuma C; Ishii Y; Kobayashi A; Ohta T; Kakutani M; Imanaka T; Ogawa N
J Pharmacol Sci; 2015 Sep; 129(1):51-8. PubMed ID: 26354408
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
[TBL] [Abstract][Full Text] [Related]
10. Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis.
Oh WK; Lee C; Seo JH; Chung MY; Cui L; Fomum ZT; Kang JS; Lee HS
Arch Pharm Res; 2009 Jan; 32(1):43-7. PubMed ID: 19183875
[TBL] [Abstract][Full Text] [Related]
11. Defining the key pharmacophore elements of PF-04620110: discovery of a potent, orally-active, neutral DGAT-1 inhibitor.
Dow RL; Andrews MP; Li JC; Michael Gibbs E; Guzman-Perez A; Laperle JL; Li Q; Mather D; Munchhof MJ; Niosi M; Patel L; Perreault C; Tapley S; Zavadoski WJ
Bioorg Med Chem; 2013 Sep; 21(17):5081-97. PubMed ID: 23871442
[TBL] [Abstract][Full Text] [Related]
12. Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1.
Yeh VS; Beno DW; Brodjian S; Brune ME; Cullen SC; Dayton BD; Dhaon MK; Falls HD; Gao J; Grihalde N; Hajduk P; Hansen TM; Judd AS; King AJ; Klix RC; Larson KJ; Lau YY; Marsh KC; Mittelstadt SW; Plata D; Rozema MJ; Segreti JA; Stoner EJ; Voorbach MJ; Wang X; Xin X; Zhao G; Collins CA; Cox BF; Reilly RM; Kym PR; Souers AJ
J Med Chem; 2012 Feb; 55(4):1751-7. PubMed ID: 22263872
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core.
Dow RL; Andrews M; Aspnes GE; Balan G; Michael Gibbs E; Guzman-Perez A; Karki K; Laperle JL; Li JC; Litchfield J; Munchhof MJ; Perreault C; Patel L
Bioorg Med Chem Lett; 2011 Oct; 21(20):6122-5. PubMed ID: 21908190
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum.
Lee SW; Rho MC; Park HR; Choi JH; Kang JY; Lee JW; Kim K; Lee HS; Kim YK
J Agric Food Chem; 2006 Dec; 54(26):9759-63. PubMed ID: 17177498
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
[TBL] [Abstract][Full Text] [Related]
18. Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.
Zhao G; Souers AJ; Voorbach M; Falls HD; Droz B; Brodjian S; Lau YY; Iyengar RR; Gao J; Judd AS; Wagaw SH; Ravn MM; Engstrom KM; Lynch JK; Mulhern MM; Freeman J; Dayton BD; Wang X; Grihalde N; Fry D; Beno DW; Marsh KC; Su Z; Diaz GJ; Collins CA; Sham H; Reilly RM; Brune ME; Kym PR
J Med Chem; 2008 Feb; 51(3):380-3. PubMed ID: 18183944
[TBL] [Abstract][Full Text] [Related]
19. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors.
Naik R; Obiang-Obounou BW; Kim M; Choi Y; Lee HS; Lee K
ChemMedChem; 2014 Nov; 9(11):2410-24. PubMed ID: 24954424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
